Terms of Service and Privacy Policy. Genetically modified, cannibal tadpoles may be the solution to Australia’s nearly century-old invasive cane toad problem ...

AstraZeneca and Merck & Co's Lynparza has been the undisputed market leader in the PARP inhibitor category for some years, but would-be competitors continue to chip away at its market share.

The biggest stories of the day delivered to your inbox.

Eight-time top 10k finisher Zophar hosts his weekly Fantasy Premier League (FPL) Q&A ahead of Gameweek 32. Here, the topics include Phil Foden (£9.2m), Gameweek 33 Bench Boost defenders and how to ...